AIP
WHWK

Ameritas Investment Partners’s Whitehawk Therapeutics WHWK Stock Holding History

Ameritas Investment Partners’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,086
Closed -$2.54K – 3251
2024
Q1 		$2.54K Hold
1,086
– – ﹤0.01% 3017
2023
Q4 		$2.19K Hold
1,086
– – ﹤0.01% 3057
2023
Q3 		$5.26K Hold
1,086
– – ﹤0.01% 2980
2023
Q2 		$7.43K Hold
1,086
– – ﹤0.01% 2982
2023
Q1 		$7.86K Hold
1,086
– – ﹤0.01% 2793
2022
Q4 		$13.9K Hold
1,086
– – ﹤0.01% 2699
2022
Q3 		$15K Hold
1,086
– – ﹤0.01% 2663
2022
Q2 		$13K Buy
+1,086
New +$16.1K ﹤0.01% 2766

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameritas Investment Partners's WHWK Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Whitehawk Therapeutics (WHWK) in Q2 2024, closing a stake of 1,086 shares — an estimated $2.54K sold.

Ameritas Investment Partners first reported a position in WHWK in Q2 2022 and held it in 8 quarters. The position peaked at $15K in Q3 2022. 65 funds tracked by Wall St. Rank hold WHWK as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Whitehawk Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,086 Whitehawk Therapeutics shares in Q2 2024, an estimated $2.54K.
  • Ameritas Investment Partners first reported a position in Whitehawk Therapeutics in Q2 2022 and held it in 8 quarters.
  • Ameritas Investment Partners's Whitehawk Therapeutics position peaked at $15K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.